GlaxoSmithKline

Syndax initiates phase I/II study in metastatic breast cancer

Monday, April 9, 2012 04:42 PM

Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company based in Waltham, Mass., has initiated a phase I/II study combining its lead product entinostat with lapatinib ditosylate (Tykerb) in patients with locally recurrent or distant relapsed metastatic breast cancer previously treated with trastuzumab (Herceptin).

More... »

GSK invests $794 million in U.K., creates jobs

Friday, March 23, 2012 12:44 PM

GlaxoSmithKline will invest more than $794 million in the U.K. across its manufacturing sites and a new facility in Cumbria to increase production of key active ingredients for its pharmaceutical products and vaccines, creating 1,000 new jobs.

More... »

GSK selects Infosys and Fabric Worldwide to optimize digital strategy

Wednesday, March 21, 2012 10:11 AM

Infosys, a provider of business consulting and technology, engineering and outsourcing services, has formed a partnership with GlaxoSmithKline (GSK), along with Fabric Worldwide, to optimize digital channels across its global consumer healthcare and pharmaceuticals business lines.

More... »

Index Ventures launches $198 million life sciences fund

Wednesday, March 21, 2012 09:26 AM

Index Ventures, a venture capital firm, has launched its first fund solely dedicated to making investments in the life sciences sector.

More... »

GSK launches U.K. apprenticeship program

Wednesday, March 14, 2012 10:37 AM

GlaxoSmithKline (GSK) has launched a new multidisciplinary apprenticeship program aimed at 16- to 24-year-olds, offering positions at the company’s U.K. manufacturing, R&D and corporate sites.

More... »

Dendreon appoints three to executive team

Wednesday, March 14, 2012 09:10 AM

Seattle, Wash.-based Dendreon has appointed three new members to its executive team:

More... »

GlaxoSmithKline and Angiochem collaborate on treatments for LSDs

Thursday, March 1, 2012 05:55 AM

Angiochem, a clinical-stage biotechnology company, has partnered with GlaxoSmithKline (GSK) to discover, develop and commercialize treatments for lysosomal storage diseases (LSDs).

More... »

Dr. Stephen Chen named chairman, CEO of Amarillo

Monday, February 27, 2012 10:10 AM

Amarillo Biosciences, a U.S. biotechnology firm, has appointed Dr. Stephen T. Chen CEO and chairman of the board.

More... »

GSK expands Australian facility, creates 58 jobs

Friday, February 10, 2012 02:05 PM

GlaxoSmithKline (GSK) is investing roughly $64 million to expand its manufacturing and drug development activities in its Boronia facility near Melbourne, Australia.

More... »

International collaboration to combat 10 neglected tropical diseases by 2020

Monday, January 30, 2012 03:49 PM

Thirteen pharmaceutical companies, the U.S., U.K. and U.A.E governments, the Bill & Melinda Gates Foundation, the World Bank and other global health organizations will join forces to eliminate or control 10 neglected tropical diseases (NTDs) by the end of the decade.

More... »